Attention-deficit Hyperactivity Disorder Clinical Trial
Official title:
The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
The goal of this clinical trial is to develop and validate an Equine Assisted Occupational Therapy Intervention for children aged 6-12 with Attention Deficit Hyperactivity Disorder. The research aims to study the effect of an EAOT intervention on cognitive-emotional aspects, daily function and participation among these children using various measurements including physiological measures (EEG, heart rate for rider and horse), questionnaires and different tasks. It aims to enable the creation of an evidence based protocol for professionals in order to provide a better suited therapy for children with ADHD and enable them to live a full life. Participants will enroll in a 12 week EAOT intervention including one session per week of 45 minutes with a waiting period prior the intervention. Participants will go through assessments prior waiting time, prior the intervention and post intervention.
Introduction: Attention deficit/hyperactivity disorder (ADHD), characterized by inattention, hyperactivity and impulsivity, is currently one of the most common diagnoses given to children. ADHD is characterized by a developmental and chronic impairment, Executive Functions (EFs), cognitive-emotional and sensory-motor functions, as well as a wide variety of difficulties in daily tasks beyond the core symptoms. Literature review indicated that current intervention protocols include pharmacological treatment and address specific aspects such as behavioral or psychological, though scarce interventions address both. Objectives: The purpose of this study is to examine the feasibility of conducting an Equine Assisted Occupational Therapy (EAOT) intervention for children with ADHD aiming to improve EFs, cognitive-emotional functions and participation. Method: A prospective cohort study with Interrupted Time-Series design will be conducted. Forty participants and their parents who were referred to EAOT will be recruited from the waiting list of Harey Yehuda stables. Assessments will take place at four time points. Time 1: baseline-when referred for EAOT. Time 2: pre-test, before first treatment session, end of 12 week waiting period. Time 3: post-test after 12 weeks of intervention and time 4: post intervention assessment, three months follow up. The intervention will be administered by a licensed EAOT, and assessments will be done by a blinded licensed occupational therapist (OT). Standardized assessment measures will be used to measure EFs, cognitive-emotional and sensory-motor aspects as well as participation at each time point. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02827188 -
Cognitive Restructuring in ADHD: Functional Training
|
N/A | |
Recruiting |
NCT05374187 -
Efficacy of Trigeminal Nerve Stimulation for ADHD
|
N/A | |
Enrolling by invitation |
NCT04229251 -
Online Mindfulness-Based Intervention for ADHD
|
N/A | |
Completed |
NCT00339729 -
Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04416360 -
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
|
N/A | |
Recruiting |
NCT01657721 -
Working Memory Training in ADHD (The Engage Study)
|
Phase 1 | |
Completed |
NCT04786730 -
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT01323192 -
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
|
Phase 3 | |
Recruiting |
NCT05165511 -
Families, Responsibility, Education, Support, and Health for Executive Function
|
N/A | |
Completed |
NCT01886469 -
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1/Phase 2 | |
Completed |
NCT01010750 -
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1 | |
Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
Completed |
NCT01624649 -
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
|
Phase 4 | |
Completed |
NCT03806946 -
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
|
||
Completed |
NCT01907360 -
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
|
Phase 1/Phase 2 |